109 related articles for article (PubMed ID: 27798863)
41. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
42. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
43. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
44. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
45. Triple-negative breast cancer: advancements in characterization and treatment approach.
Hurvitz S; Mead M
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
[TBL] [Abstract][Full Text] [Related]
46. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
47. Microtubule Acetylation-Specific Inhibitors Induce Cell Death and Mitotic Arrest via JNK/AP-1 Activation in Triple-Negative Breast Cancer Cells.
Ahn S; Kwon A; Oh Y; Rhee S; Song WK
Mol Cells; 2023 Jun; 46(6):387-398. PubMed ID: 36794420
[TBL] [Abstract][Full Text] [Related]
48. The length of the bridging chain in ansa-metallocenes influences their antiproliferative activity against triple negative breast cancer cells (TNBC).
Beauperin M; Top S; Richard MA; Plażuk D; Pigeon P; Toma S; Poláčková V; Jaouen G
Dalton Trans; 2016 Aug; 45(33):13126-34. PubMed ID: 27276499
[TBL] [Abstract][Full Text] [Related]
49. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers.
McLoughlin EC; Twamley B; O'Brien JE; Hannon Barroeta P; Zisterer DM; Meegan MJ; O'Boyle NM
Bioorg Chem; 2023 Dec; 141():106877. PubMed ID: 37804699
[TBL] [Abstract][Full Text] [Related]
50. In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer.
Bouchmaa N; Ben Mrid R; Bouargalne Y; Ajouaoi S; Cacciola F; El Fatimy R; Nhiri M; Zyad A
PLoS One; 2023; 18(2):e0272781. PubMed ID: 36757991
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Pharmacological Evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents.
Gangapuram M; Eyunni S; Redda KK
J Cancer Sci Ther; 2014 Apr; 6():161-169. PubMed ID: 25525496
[TBL] [Abstract][Full Text] [Related]
52. Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer.
Kazimir A; Götze T; Lönnecke P; Murganić B; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2024 Apr; ():e202400006. PubMed ID: 38642018
[TBL] [Abstract][Full Text] [Related]
53. Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer.
Kwon A; Lee GB; Park T; Lee JH; Ko P; You E; Ahn JH; Eom SH; Rhee S; Song WK
Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32917017
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells.
Alneyadi A; Nizami ZN; Aburawi HE; Hisaindee S; Nawaz M; Attoub S; Ramadan G; Benhalilou N; Al Azzani M; Elmahi Y; Almeqbali A; Muhammad K; Eid AH; Vijayan R; Iratni R
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345018
[TBL] [Abstract][Full Text] [Related]
55. [Vinorelbine, a Microtubule Toxin, Induces Apoptosis and Polyploidy in MX-1, a Human Triple-Negative Breast Cancer Cell Line].
Nakajima H; Furukawa C; Magae J
Gan To Kagaku Ryoho; 2019 Mar; 46(3):447-451. PubMed ID: 30914582
[TBL] [Abstract][Full Text] [Related]
56. Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15.
García-Rocha M; García-Gravalos MD; Avila J
Br J Cancer; 1996 Apr; 73(8):875-83. PubMed ID: 8611420
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1
Ana G; Kelly PM; Malebari AM; Noorani S; Nathwani SM; Twamley B; Fayne D; O'Boyle NM; Zisterer DM; Pimentel EF; Endringer DC; Meegan MJ
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33671674
[TBL] [Abstract][Full Text] [Related]
58. Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines.
Nel M; Joubert AM; Dohle W; Potter BV; Theron AE
Drug Des Devel Ther; 2018; 12():1881-1904. PubMed ID: 29983544
[TBL] [Abstract][Full Text] [Related]
59. In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPER.
Morelos-Garnica LA; Guzmán-Velázquez S; Padilla-Martínez II; García-Sánchez JR; Bello M; Bakalara N; Méndez-Luna D; Correa-Basurto J
Sci Rep; 2023 Oct; 13(1):17933. PubMed ID: 37863936
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic Agents.
Devine SM; Yong C; Amenuvegbe D; Aurelio L; Muthiah D; Pouton C; Callaghan R; Capuano B; Scammells PJ
J Med Chem; 2018 Sep; 61(18):8444-8456. PubMed ID: 30156410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
